Arcturus Therapeutics Holdings (ARCT) Capital Expenditures Growth (1y) (2019 - 2025)
Powered by 
Analysis
Arcturus Therapeutics Holdings (ARCT) Capital Expenditures Growth (1y) (2019 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -22.99% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 9.68% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 1,133.33% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | -37.81% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 142.64% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 22,433.30% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -73.62% |
| 10 | Arcturus Therapeutics Holdings | 449.65 Mn | 258.17 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 126.25% |
| Mar 31, 2025 | -42.92% |
| Sep 30, 2024 | -91.85% |
| Jun 30, 2024 | -7.34% |
| Mar 31, 2024 | -65.27% |
| Dec 31, 2023 | -77.02% |
| Sep 30, 2023 | -45.04% |
| Jun 30, 2023 | 1,439.13% |
| Mar 31, 2023 | -67.27% |
| Dec 31, 2022 | 240.52% |
| Sep 30, 2022 | 1.08% |
| Jun 30, 2022 | -91.90% |
| Mar 31, 2022 | 786.97% |
| Dec 31, 2021 | 60.40% |
| Sep 30, 2021 | 306.91% |
| Jun 30, 2021 | -18.62% |
| Mar 31, 2021 | -9.16% |
| Dec 31, 2020 | 121.27% |
| Sep 30, 2020 | 172.96% |
| Jun 30, 2020 | 66.99% |